Sopharma AD (BUL: SFA)

Sopharma AD Income Statement

Financials in millions BGN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	2,038	1,874	1,663	1,603	1,439	1,282
Other Revenue	13.74	13.53	8.5	8.04	7.31	6.53
Revenue	2,051	1,888	1,672	1,611	1,446	1,288
Revenue Growth (YoY)	12.00%	12.95%	3.73%	11.42%	12.27%	8.44%
Cost of Revenue	1,603	1,472	1,306	1,264	1,131	980.86
Gross Profit	448.37	415.51	365.37	346.96	315.22	307.26
Selling, General & Admin	294.08	255.31	215.55	221.99	213.25	195.71
Other Operating Expenses	15.55	11.69	11.76	7.3	11.84	10.38
Operating Expenses	367.51	322.92	279.51	285.48	271.87	250.09
Operating Income	80.85	92.59	85.86	61.48	43.35	57.16
Interest Expense	-12.25	-10.98	-6.02	-10.79	-12.41	-11.46
Interest & Investment Income	4.4	4.37	3.19	4.87	5.23	6.02
Earnings From Equity Investments	21.3	24.74	22.64	12.09	5.98	44.66
Currency Exchange Gain (Loss)	-1.31	-1.31	-0.13	2.29	-7.41	1.56
Other Non Operating Income (Expenses)	-2.63	-2.63	-3.19	-0.94	-0.76	-0.43
EBT Excluding Unusual Items	90.36	106.78	102.35	69	33.98	97.52
Impairment of Goodwill	-	-	-9.6	-	-3.5	-4.26
Gain (Loss) on Sale of Investments	-	-	-1.59	0.15	0.09	3.96
Gain (Loss) on Sale of Assets	4.69	4.69	1.95	38.01	0.41	4.77
Asset Writedown	0.05	-1.44	-8.46	-10.34	-2.32	-14.42
Legal Settlements	-	-	-	-	0.17	-
Other Unusual Items	0.87	0.87	0.43	0.75	2.61	0.85
Pretax Income	95.97	110.9	85.08	97.57	31.44	88.41
Income Tax Expense	9.82	11.82	8.74	5.87	6.16	4.05
Earnings From Continuing Operations	86.16	99.08	76.33	91.7	25.28	84.36
Minority Interest in Earnings	-4.25	-3.87	-5.21	-2.21	4.53	2.64
Net Income	81.91	95.21	71.12	89.5	29.81	86.99
Net Income to Common	81.91	95.21	71.12	89.5	29.81	86.99
Net Income Growth	1.15%	33.87%	-20.53%	200.27%	-65.74%	206.93%
Shares Outstanding (Basic)	164	131	121	125	126	126
Shares Outstanding (Diluted)	177	140	125	125	126	126
Shares Change (YoY)	35.29%	12.23%	-0.36%	-0.31%	-0.11%	0.08%
EPS (Basic)	0.50	0.73	0.59	0.71	0.24	0.69
EPS (Diluted)	0.46	0.68	0.57	0.71	0.24	0.69
EPS Growth	-25.27%	19.30%	-19.72%	199.57%	-65.70%	206.69%
Free Cash Flow	110.99	20.64	90.74	-96.31	-202.96	-164.48
Free Cash Flow Per Share	0.63	0.15	0.73	-0.77	-1.61	-1.31
Dividend Per Share	0.165	0.990	0.600	-	-	0.120
Dividend Growth	-89.00%	65.00%	-	-	-	140.00%
Gross Margin	21.86%	22.01%	21.86%	21.53%	21.80%	23.85%
Operating Margin	3.94%	4.90%	5.14%	3.82%	3.00%	4.44%
Profit Margin	3.99%	5.04%	4.25%	5.55%	2.06%	6.75%
Free Cash Flow Margin	5.41%	1.09%	5.43%	-5.98%	-14.03%	-12.77%
EBITDA	117.38	127.15	118.97	93.85	74.19	99.54
EBITDA Margin	5.72%	6.73%	7.12%	5.82%	5.13%	7.73%
D&A For EBITDA	36.53	34.56	33.11	32.37	30.84	42.38
EBIT	80.85	92.59	85.86	61.48	43.35	57.16
EBIT Margin	3.94%	4.90%	5.14%	3.82%	3.00%	4.44%
Effective Tax Rate	10.23%	10.66%	10.28%	6.02%	19.60%	4.59%
Advertising Expenses	-	36.96	22.06	27.41	28.5	1.46

Source: S&P Capital IQ. Standard template. Financial Sources.